Wipro GE HealthCare has announced the appointment of Chaitanya Sarawate as the Managing Director (MD), Wipro GE HealthCare and President & CEO, GE HealthCare South Asia.

He succeeds Dr Shravan Subramanyam who is leaving to pursue an opportunity outside the company. Sarawate will work closely with Dr Shravan for a smooth transition as he integrates into his new role, effective February 13, 2023, and will be reporting to Elie Chaillot, President & CEO, GE HealthCare Intercontinental.

Sarawate brings with him over two decades of corporate and healthcare experience and has been with GE HealthCare for over 12 years. In his new role, he will be responsible for strengthening company’s market leadership position in South Asia by driving localization strategy and delivering clinical excellence, access and precision care.

Prior to this, Chaitanya was the Chief Marketing & Strategy Officer for AKA (ASEAN, Korea, Australia & New Zealand), where he spearheaded organizational transformation that drove enhanced visibility, increased empowerment, and gains through segment specialisation. 

Dr Subramanyam joined Wipro GE HealthCare in 2020. During his tenure, the organisation observed robust growth and a focus on localisation, skilling and PPP (Public-Private Partnership) initiatives aligned to the national agenda of ‘Atmanirbhar Bharat’. Wipro GE HealthCare launched its PLI factory and ‘Made in India’ products, built collaborations to advance patient care pathways as well as launched the first 5G Innovation Lab for GE HealthCare globally, in Bengaluru.